General Biologicals Corporation (4117)의 가격은 얼마입니까?

General Biologicals Corporation (4117)의 가격은 $0.31640033입니다.

General Biologicals Corporation (4117)의 시가 총액은 무엇입니까?

General Biologicals Corporation (4117)의 시가 총액은 $22.25M입니다.

General Biologicals Corporation (4117) 배당금

General Biologicals Corporation (GBC) is a company dedicated to the research, development, production, and global commercialization of in-vitro diagnostic (IVD) solutions, operating extensively both within Taiwan and internationally. The company's core diagnostic offerings include advanced ELISA and chemiluminescence immunoassays, molecular and cellular diagnostic platforms, and rapid point-of-care testing (POCT) systems. Its diverse portfolio further encompasses COVID-19 related solutions, digital pathology, and contract development manufacturing organization (CDMO) services. Additionally, GBC provides essential blood screening services for detecting hepatitis and HIV, alongside crucial biomaterials such as antibody preparations and human plasma. Venturing beyond diagnostics, the company also markets a line of oral care products under its proprietary 'oh care' brand. These diagnostic systems are primarily utilized by clinics and laboratories. Founded in 1973, General Biologicals Corporation is headquartered in Hsinchu City, Taiwan.

연도	배당금 (주식 분할 조정됨)	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

배당금 (주식 분할 조정됨)

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도	배당금	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

배당금

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	배당 지급 횟수	국가
STERIS plc STE.US	84.00%	IE
Shanghai United Imaging Healthcare Co., Ltd. 688271.SS	0.00%	CN
Ypsomed Holding AG YPSN.SW	0.00%	CH
Medacta Group S.A. MOVE.SW	0.00%	CH
Jafron Biomedical Co.,Ltd. 300529.SZ	0.00%	CN

회사

배당 지급 횟수

국가